K-HEALTH in AIR - Barcelona Pilot - Cohort
Launched by INSTITUT D'INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER · May 14, 2024
Trial Information
Current as of February 19, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The study is structured as a comprehensive two-phase approach. From January to December 2024 (Phase I) the protocol focuses on the assessment, and refinement, of the four core components of the study: i) Enhanced lung function testing, ii) IAQ home monitoring, iii) Advanced digital support to innovative clinical processes, and iv) Predictive modelling for early detection and management of exacerbations. The main outcome at the end of Phase I is the design of an innovative integrated care service aiming at enhanced management of exacerbations and reduction of unplanned hospitalizations in hi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged Maximum 85 years
- • Diagnosed with chronic obstructive pulmonary conditions such as COPD or treatment-resistant asthma.
- • Exhibiting a high burden of co-morbidities, assessed above the 80th percentile of the regional risk stratification pyramid using Adjusted Morbidity Groups (AMG) scoring.
- • Residing in Barcelona-Esquerra, except for treatment-resistant asthma patients, live in any district of the city of Barcelona.
- Exclusion Criteria:
- • Dementia.
- • Inability to perform independent daily activities.
Trial Officials
JOSEP ROCA TORRENT, MD, PHD
Principal Investigator
Institut d'Investigació Biomèdica August Pi I Sunyer (FRCB-IDIBAPS)
About Institut D'investigacions Biomèdiques August Pi I Sunyer
The Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) is a leading biomedical research institute based in Barcelona, Spain, dedicated to advancing scientific knowledge and innovation in health and disease. Affiliated with the University of Barcelona, IDIBAPS fosters a multidisciplinary approach to research, integrating clinical and basic science to enhance understanding of various medical conditions. The institute emphasizes collaboration among researchers, clinicians, and industry partners to translate research findings into effective therapies and improve patient care. With a commitment to excellence, IDIBAPS plays a pivotal role in shaping the future of biomedical science and healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, , Spain
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0